Attitudes, Adoption Barriers and Projected Usage Timing for Pending Coronavirus Vaccine

AMC Global
on 21/08/2020

Ongoing AMC Global research finds two-thirds of Americans willing to get an FDA-approved vaccine to prevent COVID-19, with different attitudes on preferred usage timing

Why was the research conducted?

The study findings are designed to help clients and industry leaders navigate quickly changing consumer behavior during the pandemic.

How was the research conducted?

Weekly polling of U.S.-based general population of primary purchasers age 21+.

What are the key findings of the research?

  • Sixty-nine percent of respondents predict they will agree to be vaccinated against COVID-19 if an FDA-approved vaccine becomes available this year.
  • Americans who would not agree to a vaccine approved this year report their top barriers are concerns about side effects (68%), insufficient testing (63%), and safety (57%).
  • Timing on vaccination varies from ASAP (26%), after one month (18%), after two to three months (19%), after four to six months (8%), longer than six months (16%) to never (13%).

Full research:

Access full research
Contributor's Name: Michelle Andre